Statements (58)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:physicist
|
gptkbp:bfsLayer |
4
|
gptkbp:bfsParent |
gptkb:hemophilia_A
gptkb:von_Willebrand_disease |
gptkbp:advocates_for |
important for policy changes
|
gptkbp:affects |
primarily males
|
gptkbp:associated_with |
spontaneous bleeding
|
gptkbp:caused_by |
deficiency of factor IX
|
gptkbp:clinical_trial |
varies
ongoing |
gptkbp:community_support |
available for patients
|
gptkbp:complications |
joint damage
inhibitor development |
gptkbp:current_use |
gptkb:hemophilia_A
|
gptkbp:descendant |
X-linked recessive
|
gptkbp:diet |
regular check-ups
avoidance of contact sports education on bleeding management |
gptkbp:difficulty |
moderate
mild severe |
gptkbp:duration |
regular infusions
|
gptkbp:economic_impact |
impact on family dynamics
emotional support needed school accommodations may be necessary |
gptkbp:education |
critical for self-management
|
gptkbp:emergency_services |
required for bleeding episodes
should be in place |
gptkbp:first_described_by |
in 1952
|
gptkbp:future_plans |
improving with new therapies
|
gptkbp:genetic_diversity |
gptkb:stock_market_index
recommended |
https://www.w3.org/2000/01/rdf-schema#label |
hemophilia B
|
gptkbp:is_involved_in |
gptkb:World_Federation_of_Hemophilia
gptkb:National_Hemophilia_Foundation |
gptkbp:is_known_for |
Christmas disease
|
gptkbp:is_popular_in |
varies by country
1 in 25,000 male births |
gptkbp:manager |
preventive care
|
gptkbp:provides_information_on |
varies by region
available for management |
gptkbp:public_awareness |
gptkb:World_Hemophilia_Day
|
gptkbp:receives_funding_from |
increasing
|
gptkbp:registration |
exists for data collection
|
gptkbp:research_focus |
gptkb:physicist
new treatments |
gptkbp:risk_factor |
family history
genetic mutations |
gptkbp:screenings |
recommended for at-risk families
|
gptkbp:social_responsibility |
varies
blood tests |
gptkbp:symptoms |
joint pain
easy bruising prolonged bleeding |
gptkbp:treatment |
desmopressin
can be high expanding with research. factor IX replacement therapy |